We are live on ! Find out more
BIAF icon

bioAffinity Technologies
BIAF

17 hedge funds and large institutions have $863K invested in bioAffinity Technologies in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

78% more capital invested

Capital invested by funds: $484K → $863K (+$379K)

31% more funds holding

Funds holding: 13 → 17 (+4)

0.04% more ownership

Funds ownership: 0.07% → 0.11% (+0.04%)

Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$235K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$63.5K
3
GSC
Ground Swell Capital
South Carolina
+$52.8K
4
UBS Group
UBS Group
Switzerland
+$22.2K
5
SBIA
Sheaff Brock Investment Advisors
Indiana
+$11.6K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$33.5K
2
CS
Clear Street
New York
-$202
3
Wells Fargo
Wells Fargo
California
-$91
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$372K +$235K +3,389 +145%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$150K +$63.5K +917 +65%
CAPTRUST Financial Advisors
3
CAPTRUST Financial Advisors
North Carolina
$60.2K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$49.6K -$33.5K -484 -39%
GSC
5
Ground Swell Capital
South Carolina
$49.4K +$52.8K +762 New
State Street
6
State Street
Massachusetts
$38K – – –
SBIA
7
Sheaff Brock Investment Advisors
Indiana
$32.4K +$11.6K +167 +50%
Northern Trust
8
Northern Trust
Illinois
$29.5K – – –
Creative Planning
9
Creative Planning
Kansas
$27.2K +$1.18K +17 +4%
IA
10
IFP Advisors
Florida
$21.6K +$11.5K +166 +99%
UBS Group
11
UBS Group
Switzerland
$20.7K +$22.2K +320 New
TRCT
12
Tower Research Capital (TRC)
New York
$9.97K +$2.91K +42 +38%
Morgan Stanley
13
Morgan Stanley
New York
$2.16K +$2.29K +33 New
CC
14
Cypress Capital
Tennessee
$432 +$485 +7 New
Bank of America
15
Bank of America
North Carolina
$140 +$139 +2 New
Qube Research & Technologies (QRT)
16
Qube Research & Technologies (QRT)
United Kingdom
$82 – – –
JP Morgan Chase
17
JP Morgan Chase
New York
$39 +$69 +1 New
CS
18
Clear Street
New York
– -$202 -3 Closed
Wells Fargo
19
Wells Fargo
California
– -$91 -2 Closed

BIAF Hedge Fund Activity: Q2 2024 in Review

17 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q2 2024, worth a combined $863K — up 78% from $484K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIAF positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $235K. The largest seller was Renaissance Technologies, cutting an estimated $33.5K.

  • 17 institutional investors held bioAffinity Technologies (BIAF) as of Q2 2024, up from 13 in Q1 2024.
  • Funds reported $863K of bioAffinity Technologies stock for Q2 2024, up 78% quarter-over-quarter.
  • 6 funds opened new bioAffinity Technologies positions in Q2 2024 and 2 closed out, a net change of +4 holders.
  • The largest bioAffinity Technologies buyer in Q2 2024 was Vanguard Group, an estimated $235K added.
  • The largest bioAffinity Technologies seller in Q2 2024 was Renaissance Technologies, an estimated $33.5K sold.

Based on aggregated 13F filings for Q2 2024.